Abstract
Study Design:
Retrospective chart review.
Objectives:
The present study was performed to analyze the impact of ankylosing spondylitis (AS) in developing heterotopic ossification (HO) in patients following spinal cord injury.
Setting:
Department of Spinal Cord Injury and Department of General and Trauma Surgery, BG-University Hospital Bergmannsheil Bochum, Ruhr-University Bochum, Germany.
Materials and Methods:
Between January 2003 and December 2015, 67 patients with AS and SCI were included in the study. The control group consisted of 141 patients with SCI and without AS. The definitive diagnosis of HO was made via magnetic resonance imaging or computed tomography. Primary outcome measure was to analyze the impact of AS on the development of HO.
Results:
Fifteen out of 67 AS patients (22.4%) had a diagnosed HO. In the control group, 28 of 141 patients (19.9%) suffered from HO. Patients with AS had no significant higher risk for HO development compared with patients without AS (RR=1.16; 95% CI=0.65–2.09). However, patients with a complete neurological deficit had a twofold higher risk for HO development (RR=2.55; 95% CI=1.26–5.16).
Conclusions:
AS does not increase the risk for HO development in patients with spinal cord injury.
Similar content being viewed by others
Introduction
Heterotopic ossification (HO) is the presence of bone in non-skeletal tissue and can occur in up to 22% of patients with spinal cord injury (SCI).1, 2 It may cause severe limitation of the range of motion of the patient’s joints, increasing the burden of the disease. Despite its high incidence, the exact pathogenesis of HO is still unknown. Previous research has identified several risk factors for the development of HO. These are as follows: local micro-trauma, unbalance of calcitonin and parathyroid hormone levels, genetic predisposition, immobilization or venous stasis.1, 2 Known clinical risk factors are as follows: concomitant thoracic trauma; a complete lesion (AIS A); the presence of spasticity or pneumonia; and having required a tracheostomy.1, 3
Ankylosing spondylitis (AS) is a seronegative spondyloarthropathy associated with the presence of the HLA-B27 gene that causes erosions and ankylosis of the spine and of the sacroiliac joints. The presence of AS has been identified as a risk factor for HO development in patients who undergo total hip arthroplasty (THA). In a recent review, Zhang et al.4 reported a twofold elevation of the risk of developing HO in patients with AS following THA.
The impact of AS on HO in spinal cord-injured patients remains unknown. A literature search revealed no recent studies addressing this question, only decades-old studies with different claims on the influence of AS and HLA-B27 on spinal cord-injured patients. In 1981, Larson et al.5 reported on the increased prevalence of HLA-B27 in patients with ectopic ossification following traumatic SCI. In contrast to this study, Garland et al.6 concluded in 1984 that there was no positive correlation between the HLA antigen system and HO onset subsequent to brain trauma or SCI. However, to our knowledge, there is no reliable evidence indicating whether AS increases the risk of developing HO in spinal cord-injured patients.
The main objective of the current study was to determine whether AS increases the risk for the development of HO in spinal cord-injured patients. A secondary aim was to describe the demographic characteristics, clinical variables, injury patterns and complications of this group of patients.
Materials and methods
This retrospective cohort study was conducted after obtaining approval from our institutional review board. Patients over the age of 18 years with a traumatic SCI and a concomitant diagnosis of AS, and those who were treated in the Department of Spinal Cord Injuries at our University Hospital between January 2003 and December 2015 were eligible for the study. Those patients with a confirmed diagnosis of AS were enrolled as the exposed group (N=67). A twice-large group of spinal cord-injured patients without AS was randomly selected and enrolled into the unexposed group (N=141).
The main outcome variable was a confirmed diagnosis of HO. The diagnosis of HO was accomplished using a previously described protocol. According to this protocol, patients are screened biweekly by ultrasound examinations of the hip and shoulder joints by our experienced radiologists. In case of suspicion for HO, the presumptive clinical diagnosis was confirmed with either computed tomography or magnetic resonance imaging.
Information about the following variables was collected from the medical records for all patients: date of birth, sex, severity of spinal cord lesion according to the American Spinal Injury Association (ASIA) impairment scale (AIS),7 mechanism of injury, time interval between the SCI and HO diagnosis (in days), length of hospital stay, laterality of the HO lesion, spasticity, thoracic injury, pressure ulcers, pneumonia and tracheostomy.
Statistical analysis
The relative risk of developing HO in spinal cord-injured patients with AS was estimated using a generalized linear model with a Poisson distribution, a log link and a robust variance estimator.8, 9 To adjust for confounding, the following predictors were selected a priori based on previous research and were also included in the model: spasticity, thoracic injury, complete SCI, pressure ulcers, pneumonia and tracheostomy.1 Confidence intervals at the 95% level were calculated over 200 bootstrap repetitions.10, 11 Descriptive statistics are presented for all other variables. All analyzes were performed using Stata/MP 13.0 for Windows (StataCorp LP, College Station, TX, USA).
Results
Complete data for all variables of interest were collected for all patients in the study. No patient was excluded because of missing data. In total, 208 patients were included in this study: 67 patients were enrolled into the AS group and 141 patients were enrolled into the No AS group. As shown in Table 1, both groups had a similar distribution of demographic and clinical variables.
The exposed patient cohort consisted of 57 male (85.1%) and 10 female patients (14.9%), with a mean age of 68.1 years (37–88 years; s.d.=11.6). Thirty-three patients were paraplegic (49.3%) and 34 patients were tetraplegic (50.7%). Thirty-three out of 67 patients (49.3%) had a complete lesion according to the ASIA impairment scale (AIS A); five patients (7.5%) had an AIS B lesion; nine patients (13.4%) had an AIS C lesion; and twenty patients (29.9%) had an AIS D lesion.
All patients had a traumatic SCI. The most common reason was a simple fall, for example, from a step (48 patients, 71.6%), followed by vehicle accident (9 patients, 13.4%). Forty-three patients underwent surgery within 72 h of admission (64.2%), twenty-one patients were treated after 72 h (31.3%) and three were treated conservatively. The predominant surgical technique was a dorsal spondylodesis (39 patients, 58.2%), followed by 15 patients who received a dorso-ventral spondylodesis (22.4%).
Out of 67 patients with AS, 15 (22.4%) had a confirmed diagnosis of HO, compared with 25 out of the 141 (17.7%) patients without AS. The mean time interval between the initial trauma and the diagnosis of HO was 59.9 days±31.2 (range, 19–143 days). In the majority of the cases, HO affected both hips (13 patients, 86.7%). In the remaining two cases (13.3%), HO occurred unilaterally. Bursitis trochanteric occurred in 4 of 15 HO patients (26.7%). Five of fifteen HO patients received NSAID in the form of Ibuprofen. All patients received a therapeutic radiation, with 13 patients (86.7%) receiving 7 Gy and 15 MeV and the remaining two patients (13.3%) were treated with 7 Gy and 6 MeV. In two cases, HO recurrence (13.3%) occurred. In these cases, after a repeated radiation therapy with 7 Gy and 15 MeV, no HO relapse occurred. No patient developed any side effects related to the radiation therapy. In the control group, 28 out of 141 patients (19.9%) suffered from HO.
The risk of HO was not significantly higher for patients with AS (RR=1.16; 95% CI=0.65–2.09) (Figure 1). However, patients with a complete neurological deficit had more than a twofold increase in the risk of HO development (RR=2.55; 95% CI=1.26–5.16) (Figure 1). The risk of HO increased almost twofold (RR=1.82; 95% CI=0.99–3.35) in the presence of pressure ulcers. Table 2 shows the clinical characteristics of the patients distributed by outcome.
During the hospital stay, 7 patients suffered from deep vein thrombosis, 2 patients had a pulmonary embolism, 41 patients suffered from pneumonia and received antibiotic treatment, and 21 patients developed a pressure sore. The most common localization for pressure ulcers was the sacral region (15 patients, 71.4%), which mainly impressed with second-grade severity according to the European Pressure Ulcer Advisory Panel Classification (13 patients, 61.9%).12
Discussion
To our knowledge, this is the largest retrospective study on the relationship between AS and the development of HO following a SCI. We found no evidence that AS increases the risk of HO in spinal cord-injured patients. Only the completeness of the lesion and the presence of pressure ulcers showed an increase in the risk of developing HO in this cohort.
The relationship between AS and the development of HO has been previously described for patients who undergo THA.13 Zhu et al.14 conducted a meta-analysis of the risk factors of HO in THA patients, reporting an elevated occurrence of HO in patients with AS.
In contrast, our study results present that AS does not increase the risk for HO development in patients with SCI.
The prevalence of HO in AS patients seems to be decreasing over time,15 with the HO prevalence in AS patients following THA reported in 1967 as 62%, whereas in 2012, the prevalence was reported as 6.4%. As discussed by the authors, evolving surgical techniques, such as minimally invasive procedures, or innovations in implant design, may have helped lower the incidence of HO after THA.
In comparison to the current reports on the prevalence of HO in THA, the prevalence of around 20% observed in spinal cord-injured patients in this study seems relatively high. In the special case of neurogenic HO in SCI patients, this prevalence fits into the observations of average HO occurrence in patients without AS: In 2012, Citak et al.1 reported on a HO incidence in SCI patients of 21.9%. A similar incidence of HO with 20% has already been reported in 1992 by Wittenberg et al.2 Interestingly, the incidence of HO did not change over the last 20 years, although the surgical technique (for example, percutaneous stabilization) has changed over the years.
One reason for the continuing high prevalence of HO in SCI patients might be the different pathogenesis of neurogenic and traumatic HO development, especially the fact that patients with a complete neurological deficit had a significantly higher risk of HO development. Another explanation might be the fact that patients with a concomitant pelvic trauma have no significant increase in HO incidence. We assume that the pathogenesis of neurogenic HO is not associated with local trauma of the affected area. In the largest clinical study analyzing the clinical risk factors for HO, Citak et al. reported on the relationship between HO development and several factors, such as pneumonia, thoracic trauma, and the presence of a tracheostomy. All those factors are associated with inflammatory reactions of the lung. Those parameters might be a key factor for HO development, as it is also known that lung disease may lead to new bone formation. Various possible mechanisms for this effect have been proposed, including nerve stimulation, secretion of growth factors and overproduction of prostaglandin E2.16, 17, 18, 19
In conclusion, our study showed that patients with AS are not at higher risk for HO development, whereas patients with a complete neurological deficit have a two-fold higher risk of developing HO. Adequate regular screening of patients with a complete neurological deficit could increase the number of early detected HO.
Data archiving
There were no data to deposit.
References
Citak M, Suero EM, Backhaus M, Aach M, Godry H, Meindl R et al. Risk factors for heterotopic ossification in patients with spinal cord injury: a case-control study of 264 patients. Spine 2012; 37: 1953–1957.
Wittenberg RH, Peschke U, Botel U . Heterotopic ossification after spinal cord injury. Epidemiology and risk factors. J Bone Joint Surg Br 1992; 74: 215–218.
Estrores IM, Harrington A, Banovac K . C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury. J Spinal Cord Med 2004; 27: 434–437.
Zhang F, Chen W, Zhang Q, Liu S, Zhang Y . Incidence and risk factors for heterotopic ossification after total hip arthroplasty: a meta-analysis. Arch Orthop Trauma Surg 2015; 135: 1307–1314.
Larson JM, Michalski JP, Collacott EA, Eltorai D, McCombs CC, Madorsky JB . Increased prevalence of HLA-B27 in patients with ectopic ossification following traumatic spinal cord injury. Rheumat Rehabil 1981; 20: 193–197.
Garland DE, Alday B, Venos KG . Heterotopic ossification and HLA antigens. Arch Phys Med Rehabil 1984; 65: 531–532.
Maynard FM Jr., Bracken MB, Creasey G, Ditunno JF Jr., Donovan WH, Ducker TB et al. International Standards for Neurological and Functional Classification of. Spinal Cord Injury. American Spinal Injury Association. Spinal Cord 1997; 35: 266–274.
Cummings P . Methods for estimating adjusted risk ratios. Stata J 2009; 9: 175–196.
McNutt L-A . Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes. Am J Epidemiol. 2003; 157: 940–943.
Efron B . Nonparametric estimates of standard error: The jackknife, the bootstrap and other methods. Biometrika 1981; 68: 589–599.
Harrell FE . Regression Modeling Strategies, 1st edn. Springer-Verlag New York, Inc: Secaucus, NJ, USA. 2001; ISBN: 0387952322.
Stausberg J, Kiefer E . Classification of pressure ulcers: a systematic literature review. Stud Health Technol Inform. 2009; 146: 511–515.
Thilak J, Panakkal JJ, Kim TY, Goodman SM, Lee SS, Salvati EA . Risk Factors of Heterotopic Ossification Following Total Hip Arthroplasty in Patients With Ankylosing Spondylitis. J Arthroplasty 2015; 30: 2304–2307.
Zhu Y, Zhang F, Chen W, Zhang Q, Liu S, Zhang Y . Incidence and risk factors for heterotopic ossification after total hip arthroplasty: a meta-analysis. Arch Orthop Trauma Surg 2015; 135: 1307–1314.
Putnis SE, Wartemberg GK, Khan WS, Agarwal S . A Literature Review of Total Hip Arthroplasty in Patients with Ankylosing Spondylitis: Perioperative Considerations and Outcome. Open Orthop J 2015; 30: 483–488.
Treasure T . Hypertrophic pulmonary osteoarthropathy and the vagus nerve: an historical note. J R Soc Med 2006; 99: 388–390.
Spicknall KE, Zirwas MJ, English JC . III. Clubbing: an update on diagnosis, differential diagnosis, athophysiology, and clinical relevance. J Am Acad Dermatol 2005; 52: 1020–1028.
Kozak KR, Milne GL, Morrow JD, Cuiffo BP . Hypertrophic osteoarthropathy pathogenesis: a case highlighting the potential role for cyclo-oxygenase-2-derived prostaglandin E2. Nat Clin Pract Rheumatol 2006; 2: 452–456.
Atkinson S, Fox SB . Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol 2004; 203: 721–728.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ohlmeier, M., Karras, P., Suero, E. et al. Ankylosing spondylitis does not increase the risk of neurogenic heterotopic ossification in patients with a spinal cord injury: a retrospective cohort study. Spinal Cord 55, 213–215 (2017). https://doi.org/10.1038/sc.2016.143
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sc.2016.143